89bio, Inc. (NASDAQ:ETNB) Receives $27.56 Consensus PT from Analysts
Shares of 89bio, Inc. (NASDAQ:ETNB – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating […]
